Evaluation of good review practices in member authorities of the East African Medicines Regulatory Harmonisation initiative: strategies for alignment with African medicines agency

被引:1
|
作者
Ngum, Nancy [1 ,2 ]
Ndomondo-Sigonda, Margareth [2 ]
Habonimana, Remy [3 ]
Siyoi, Fred [4 ]
Irasabwa, Clarisse [5 ]
Ojukwu, Julia [6 ]
Apolinary, Felchism [7 ]
Okello, Andrew [8 ]
Ahmada, Sabrina [9 ]
Walker, Stuart [1 ,10 ]
Salek, Sam [1 ,11 ]
机构
[1] Univ Hertfordshire, Sch Life & Med Sci, Dept Clin & Pharmaceut Sci, Hatfield, England
[2] African Union Dev Agcy New Partnership Afr Dev AUD, Johannesburg, South Africa
[3] Burundi Food & Med Regulatory Author ABREMA, Bujumbura, Burundi
[4] Pharmacy & Poisons Board PPB, Nairobi, Kenya
[5] Rwanda Food & Drugs Author, Kigali, Rwanda
[6] Drug & Food Control Author DFCA, Juba, South Sudan
[7] Tanzania Med & Med Devices Author TMDA, Dodoma, Tanzania
[8] Natl Drug Author, Kampala, Uganda
[9] Zanzibar Food & Drugs Author ZFDA, Dodoma, Tanzania
[10] Ctr Innovat Regulatory Sci, London, England
[11] Inst Med Dev, London, England
关键词
East African Medicines Regulatory Harmonisation (EAC-MRH); good assessment procedure; good review practices; regulatory reliance; African Medicines Agency (AMA);
D O I
10.3389/fmed.2024.1437970
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction The East African Community Medicines Regulatory Harmonisation (EAC-MRH) programme was established to address challenges faced by national regulatory authorities (NRAs) of the region. Work sharing through joint assessments and inspections was adopted to manage limited resources and capacity; however, NRA good review practices (GrevP) are also a key determinant to success. This study evaluated GReVP among the EAC-MRH NRAs and mapped required strategies for countries to align themselves with the African Medicines Agency (AMA).Methods A validated questionnaire (Optimising Efficiency in Regulatory Agency-OpERA) that standardises and captures review processes was completed by the head of the medicines registration division in each NRA. A country report based on the completed questionnaire was developed for each NRA and validated by the heads of the respective authorities.Results The population and size of the NRAs vary and four of the countries have semi-autonomous authorities and three NRAs are autonomous. The Burundi and South Sudan authorities were fully government funded, Kenya and Uganda entirely from fees, while Rwanda, Tanzania and Zanzibar were partially funded from different sources. All authorities except South Sudan, which does not receive or review applications had backlogs. Authority fees varied based on the different application categories. Key milestones for standardised regulatory processes are implemented in all authorities. Queue times range from a few weeks to about one year. Three NRAs use internal technical agency staff for scientific assessments and three use both internal and external experts. Clock stop time varies and target timelines for review committee range from one day to three months. All the NRAs implement some best practices on quality measures, transparency and communication. Some have activities for transparency improvement but with minimal attention to training and education. Most employ some quality decision-making practices.Discussion GrevP in EAC-MRH NRAs still needs to be improved and it is imperative that these authorities streamline and harmonise their practices. Increasing human resources and an investment in training and education of staff will enable the implementation of all measures for GRevP. This is vital, as the effectiveness and efficiency of the AMA will depend on the strength of these NRAs.
引用
收藏
页数:10
相关论文
共 29 条
  • [21] Optimizing the East African Community's Medicines Regulatory Harmonization initiative in 2020-2022: A Roadmap for the Future
    Arik, Mawien
    Bamenyekanye, Emmanuel
    Fimbo, Adam
    Kabatende, Joseph
    Kijo, Agnes Sitta
    Simai, Burhani
    Siyoi, Fred
    Azatyan, Samvel
    Ambali, Aggrey
    Cooke, Emer
    Mashingia, Jane H.
    Mwesigye, John Patrick
    Ndomondo-Sigonda, Margareth
    Sillo, Hiiti
    Sonoiya, Stanley
    Tanui, Paul
    Ward, Mike
    Delano, Thomas
    PLOS MEDICINE, 2020, 17 (08)
  • [22] US Food and Drug Administration and European Medicines Agency Launch Good Clinical Practices Initiative
    Peek, Richard
    Reddy, K. Rajender
    GASTROENTEROLOGY, 2009, 137 (04) : 1195 - 1196
  • [23] The process of ratifying the treaty to establish the African Medicines Agency: perspectives of national regulatory agencies
    Ncube, Bakani Mark
    Dube, Admire
    Ward, Kim
    HEALTH POLICY AND PLANNING, 2024, 39 (05) : 447 - 456
  • [24] Evaluation of the Good Review Practices of Countries Participating in the Southern African Development Community: Alignment and Strategies for Moving Forward
    Sithole, Tariro
    Mahlangu, Gugu
    Capote, Velma
    Sitoie, Tania
    Shifotoka, Saren
    Gaeseb, Johannes
    Padayachee, Silverani
    Sehloho, Tohlang
    Khea, Akida
    Fimbo, Adam
    Munkombwe, Zuma
    Mwale, Bernice
    Salek, Sam
    Walker, Stuart
    FRONTIERS IN MEDICINE, 2021, 8
  • [25] Quality of medicines: Deficiencies found by Brazilian Health Regulatory Agency (ANVISA) on good manufacturing practices international inspections
    Cornelio Geyer, Andrea Renata
    Sousa, Varley Dias
    Silveira, Damaris
    PLOS ONE, 2018, 13 (08):
  • [26] Assessment of the effectiveness and efficiency of the economic community of West African States Medicines Regulatory Harmonization initiative by the pharmaceutical industry
    Owusu-Asante, Mercy
    Darko, Delese Mimi
    Walker, Stuart
    Salek, Sam
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [27] Advancing African Medicines Agency through Global Health Diplomacy for an Equitable Pan-African Universal Health Coverage: A Scoping Review
    Chattu, Vijay Kumar
    Dave, Vishal B.
    Reddy, K. Srikanth
    Singh, Bawa
    Sahiledengle, Biniyam
    Heyi, Demisu Zenbaba
    Nattey, Cornelius
    Atlaw, Daniel
    Jackson, Kioko
    El-Khatib, Ziad
    Eltom, Akram Ali
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (22)
  • [28] A narrative review on problems in product quality, regulatory system constraints, and the concept of quality by design as a solution for quality assurance of African medicines
    Hassen, Hassen Kebede
    Mekasha, Yesuneh Tefera
    Tegegne, Addisu Afrassa
    Ozalp, Yildiz
    FRONTIERS IN MEDICINE, 2024, 11
  • [29] Evaluation of the Review Models and Approval Timelines of Countries Participating in the Southern African Development Community: Alignment and Strategies for Moving Forward
    Sithole, Tariro
    Mahlangu, Gugu
    Capote, Velma
    Sitoie, Tania
    Shifotoka, Saren
    Gaeseb, Johannes
    Danks, Lorraine
    Nkambule, Portia
    Juma, Alex
    Fimbo, Adam
    Munkombwe, Zuma
    Mwale, Bernice
    Salek, Sam
    Walker, Stuart
    FRONTIERS IN MEDICINE, 2021, 8